Sponsored by:
Case 1: Optomap® Color Fundus Image OD Anti-VEGF5,6 intra-vitreal injections were discussed with patient previously but she refused. The progression over this 3 month period was fully explained to the patient with the aid of the images above. It appears that she has agreed to Avastin treatment and additional PRP.
Case 1: Optomap® plus with ResMax™ Color Fundus Image OS 25 months after V1
Case 1: Optomap® plus with ResMax™ Color Fundus Image OD 25 months after V1
Case 1: Optomap® Color Fundus Image OS 25 months after V1
Case 1: Optomap® plus with ResMax™ Fundus Image Magnification OS Initial Presentation/ Visit 1 (V1) 18 months after V1 22 months after V1
Case 1: Optomap® plus with ResMax™ Fundus Image Magnification OD Initial Presentation/ Visit 1 (V1) 18 months after V1 22 months after V1
Case 1: Optomap® Fluorescein Angiography OD and OS 22 months after V1
The inferior vitreous hemorrhage is beginning to spread out and resolve.
